Peptide-decorated nanocarriers penetrating the blood-brain barrier for imaging and therapy of brain diseases

Adv Drug Deliv Rev. 2022 Aug:187:114362. doi: 10.1016/j.addr.2022.114362. Epub 2022 May 30.

Abstract

Blood-Brain Barrier (BBB) is one of the most important physiological barriers strictly restricting the substance exchange between blood and brain tissues. While the BBB protects the brain from infections and toxins and maintains brain homeostasis, it is also recognized as the main obstacle to the penetration of therapeutics and imaging agents into the brain. Due to high specificity and affinity, peptides are frequently exploited to decorate nanocarriers across the BBB for diagnosis and/or therapy purposes. However, there are still some challenges that restrict their clinical application, such as stability, safety and immunocompatibility. In this review, we summarize the biological and pathophysiological characteristics of the BBB, strategies across the BBB, and recent progress on peptide decorated nanocarriers for brain diseases diagnosis and therapy. The challenges and opportunities for their translation are also discussed.

Keywords: Blood-brain barrier; Brain diseases; Delivery system; Imaging; Peptide.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Transport
  • Blood-Brain Barrier*
  • Brain / diagnostic imaging
  • Brain Diseases* / diagnostic imaging
  • Brain Diseases* / drug therapy
  • Drug Delivery Systems / methods
  • Humans
  • Peptides / chemistry

Substances

  • Peptides